"The US Food and Drug Administration (FDA) has approved an expanded indication for onabotulinum toxin A (Botox, Actavis) for the treatment of adults with upper limb spasticity, according to a company news release.
The expanded i"...
Patients' caregivers should be informed that the effects of ibuprofen on infants' neurodevelopmental outcome, growth and disease process with prematurity have not been assessed in long-term studies.
NeoProfen may alter signs of infection. Patients' caregivers should be informed that the infant will be carefully monitored for any signs of infection.
Patients' caregivers should be informed that like other NSAIDS, NeoProfen can inhibit clot formation therefore their infant will be monitored for any signs of bleeding.
Patients' caregivers should be informed that the infants' blood will be tested for increased levels of total bilirubin.
Patients' caregivers should be informed that the infants' skin and tissues will be monitored as leakage from administration may be irritating to tissue.
Last reviewed on RxList: 1/26/2016
This monograph has been modified to include the generic and brand name in many instances.
Additional NeoProfen Information
- NeoProfen Drug Interactions Center: ibuprofen lysine (pf) iv
- NeoProfen Side Effects Center
- NeoProfen FDA Approved Prescribing Information including Dosage
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.